These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 24199627)

  • 1. Receptor activity-modifying protein-dependent effects of mutations in the calcitonin receptor-like receptor: implications for adrenomedullin and calcitonin gene-related peptide pharmacology.
    Watkins HA; Walker CS; Ly KN; Bailey RJ; Barwell J; Poyner DR; Hay DL
    Br J Pharmacol; 2014 Feb; 171(3):772-88. PubMed ID: 24199627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-function analyses reveal a triple β-turn receptor-bound conformation of adrenomedullin 2/intermedin and enable peptide antagonist design.
    Roehrkasse AM; Booe JM; Lee SM; Warner ML; Pioszak AA
    J Biol Chem; 2018 Oct; 293(41):15840-15854. PubMed ID: 30139742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-function analysis of amino acid 74 of human RAMP1 and RAMP3 and its role in peptide interactions with adrenomedullin and calcitonin gene-related peptide receptors.
    Qi T; Ly K; Poyner DR; Christopoulos G; Sexton PM; Hay DL
    Peptides; 2011 May; 32(5):1060-7. PubMed ID: 21402116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing the Mechanism of Receptor Activity-Modifying Protein Modulation of GPCR Ligand Selectivity through Rational Design of Potent Adrenomedullin and Calcitonin Gene-Related Peptide Antagonists.
    Booe JM; Warner ML; Roehrkasse AM; Hay DL; Pioszak AA
    Mol Pharmacol; 2018 Apr; 93(4):355-367. PubMed ID: 29363552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor Activity-modifying Proteins 2 and 3 Generate Adrenomedullin Receptor Subtypes with Distinct Molecular Properties.
    Watkins HA; Chakravarthy M; Abhayawardana RS; Gingell JJ; Garelja M; Pardamwar M; McElhinney JM; Lathbridge A; Constantine A; Harris PW; Yuen TY; Brimble MA; Barwell J; Poyner DR; Woolley MJ; Conner AC; Pioszak AA; Reynolds CA; Hay DL
    J Biol Chem; 2016 May; 291(22):11657-75. PubMed ID: 27013657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular effects of exogenous adrenomedullin and CGRP in Ramp and Calcrl deficient mice.
    Pawlak JB; Wetzel-Strong SE; Dunn MK; Caron KM
    Peptides; 2017 Feb; 88():1-7. PubMed ID: 27940069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Basis for Receptor Activity-Modifying Protein-Dependent Selective Peptide Recognition by a G Protein-Coupled Receptor.
    Booe JM; Walker CS; Barwell J; Kuteyi G; Simms J; Jamaluddin MA; Warner ML; Bill RM; Harris PW; Brimble MA; Poyner DR; Hay DL; Pioszak AA
    Mol Cell; 2015 Jun; 58(6):1040-52. PubMed ID: 25982113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shared and separate functions of the RAMP-based adrenomedullin receptors.
    Kuwasako K; Kitamura K; Nagata S; Hikosaka T; Takei Y; Kato J
    Peptides; 2011 Jul; 32(7):1540-50. PubMed ID: 21645567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective CGRP and adrenomedullin peptide binding by tethered RAMP-calcitonin receptor-like receptor extracellular domain fusion proteins.
    Moad HE; Pioszak AA
    Protein Sci; 2013 Dec; 22(12):1775-85. PubMed ID: 24115156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor activity-modifying protein dependent and independent activation mechanisms in the coupling of calcitonin gene-related peptide and adrenomedullin receptors to Gs.
    Woolley MJ; Reynolds CA; Simms J; Walker CS; Mobarec JC; Garelja ML; Conner AC; Poyner DR; Hay DL
    Biochem Pharmacol; 2017 Oct; 142():96-110. PubMed ID: 28705698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of components of the CGRP-receptor family in human coronary and human middle meningeal arteries: functional implications.
    de Vries T; Schutter D; van den Bogaerdt A; Vincent A; Dammers R; Danser AHJ; MaassenVanDenBrink A
    J Headache Pain; 2024 Oct; 25(1):176. PubMed ID: 39390360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the single transmembrane domain of human receptor activity-modifying protein 3 in adrenomedullin receptor internalization.
    Kuwasako K; Kitamura K; Nagata S; Nozaki N; Kato J
    Biochem Biophys Res Commun; 2012 Apr; 420(3):582-7. PubMed ID: 22445753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The third extracellular loop of the human calcitonin receptor-like receptor is crucial for the activation of adrenomedullin signalling.
    Kuwasako K; Hay DL; Nagata S; Hikosaka T; Kitamura K; Kato J
    Br J Pharmacol; 2012 May; 166(1):137-50. PubMed ID: 22142144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenomedullin 2/intermedin is a slow off-rate, long-acting endogenous agonist of the adrenomedullin
    Babin KM; Karim JA; Gordon PH; Lennon J; Dickson A; Pioszak AA
    J Biol Chem; 2023 Jun; 299(6):104785. PubMed ID: 37146967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-induced internalization, recycling, and resensitization of adrenomedullin receptors depend not on CLR or RAMP alone but on the receptor complex as a whole.
    Nag K; Sultana N; Kato A; Dranik A; Nakamura N; Kutsuzawa K; Hirose S; Akaike T
    Gen Comp Endocrinol; 2015 Feb; 212():156-62. PubMed ID: 24815888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
    Qi T; Christopoulos G; Bailey RJ; Christopoulos A; Sexton PM; Hay DL
    Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcitonin and Amylin Receptor Peptide Interaction Mechanisms: INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYING PROTEINS.
    Lee SM; Hay DL; Pioszak AA
    J Biol Chem; 2016 Apr; 291(16):8686-700. PubMed ID: 26895962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide ligand interaction with maltose-binding protein tagged to the calcitonin gene-related peptide receptor: The inhibitory role of receptor N-glycosylation.
    Lee S
    Peptides; 2022 Apr; 150():170735. PubMed ID: 35007660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ectodomain structures of the CGRP and AM receptors.
    Kusano S; Yokoyama S
    Curr Protein Pept Sci; 2013 Aug; 14(5):375-85. PubMed ID: 23745701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel peptide antagonists of adrenomedullin and calcitonin gene-related peptide receptors: identification, pharmacological characterization, and interactions with position 74 in receptor activity-modifying protein 1/3.
    Robinson SD; Aitken JF; Bailey RJ; Poyner DR; Hay DL
    J Pharmacol Exp Ther; 2009 Nov; 331(2):513-21. PubMed ID: 19644039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.